Furthermore, naringenin administration decreased plasma glucose levels in STZ-induced diabetic rats [78], improved insulin sensitivity in fructose-fed insulin resistant rats [79], and reduced insulin resistance in HFD mice [80]. The gene discussed is INS; the disease is Insulin resistance.